These results indicated that the ClC-3/SGK1 regulatory axis was a positive regulator of the chloride current in the membrane, and the antitumor effect of olaparib was related to the level of the activated chloride current in STAD cells. This evidence concerns the gene SGK1 and gastric adenocarcinoma.